Abstract
Introduction
Surgical procedures induce an endocrine, metabolic and inflammatory response in the body that causes early and late changes in homeostasis with protein catabolism. These changes are directly related to the intensity of the surgical trauma induced. 1 Although this set of physiological changes have a biological function to facilitate the healing of injured tissue when the aggression is intense and prolonged, as occurs in major surgeries, the response to trauma becomes, in itself, a cause of increased morbidity and mortality. 2 Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are subject to various forms of aggression, such as the exposure of blood to the non-physiological environment of CPB circuits, acute hemodilution and activation of the coagulation cascade and 7 the complement system. As expected, many of these patients undergo intense physiological changes that may persist for several days. 2, 3 The systemic use of high doses of opioids and the neuraxial blockade with a local anesthetic seem to be able to modulate this neuroendocrine response to surgical stress. Both techniques, however, have their drawbacks, such as the respiratory depression prolonged by opioids and the hypotension triggered by neuraxial blockade. 4, 5 Clonidine, a drug belonging to the class of ␣-2 agonists, has been associated with anesthetic-surgical procedures because of its ability to promote hemodynamic stability, 6 to prolong the analgesia time of local anesthetics and to act in the treatment of postoperative pain. 8, 9 In addition, clonidine revealed the ability to modulate the response to surgical stress and a significant application in the treatment of chronic pain.
10---13 Some studies also suggest that clonidine acts to reduce perioperative morbidity and mortality in patients at risk for coronary disease. 14, 15 Numerous studies have shown that clonidine, when combined with local anesthetics and opioids by spinal route, plays a role potentiating their actions. However, spinal clonidine, as single drug, has been scarcely studied. This research aims to assess the role of clonidine in the endocrinemetabolic stress response in adult patients undergoing cardiac surgery with CPB, with the use of troponin I, blood glucose, lactate and cortisol as markers.
Method
All patients underwent a similar technique for general anesthesia, with puncture of two peripheral veins, peripheral arterial catheter and induction of general anesthesia with etomidate 0.2---0.5 mg kg −1 or propofol 1.0---2.5 mg kg −1 , fentanyl up to 5 g kg −1 and pancuronium or vecuronium 0.1 mg kg −1 . Maintenance of anesthesia was performed with fentanyl at a maximum total dose of 25 g kg −1 , distributed during the procedure, isoflurane at a maximum concentration of 2.5% and repetition of neuromuscular blocker as needed. Vasoactive drugs could be used at any time at the discretion of the anesthesiologist.
The study excluded patients with contraindications to spinal block, history of acute myocardial infarction within the past six months, emergency surgery and use of corticosteroids or clonidine.
The patients allocated to the clonidine group were placed in lateral decubitus position and underwent lumbar puncture with disposable needle 25 G type Quincke, immediately after tracheal intubation. As soon as the liquor flowed through the needle, 1 g kg −1 clonidine was administered, using a 1-mL syringe. An interval of at least one hour between lumbar puncture and heparin administration was observed. Subsequently, urinary catheterization and installation of a central venous catheter were performed.
All patients were monitored with continuous ECG with ST segment analysis, nasopharyngeal temperature, invasive blood pressure (MAP), capnography, pulse oximetry, urine output, blood gas, ventilatory monitoring with spirometry and gas analysis.
Blood for glucose, lactate and cortisol determination was collected on three consecutive occasions: at the time of arterial puncture for invasive blood pressure monitoring (T1), 10 min after the first dose for cardioplegia (T2), and during skin suture (T3). Troponin I values at Times 1 and Este é um artigo Open Access sob a licença de CC BY-NC-ND 3 were measured. We also assessed the variation in results between T2---T1, T3---T2 and T3---T1.
CPB was performed with Braile Biomedica ® or Nipro ® equipment, with oxygenators of the respective brands. For the infusion of blood from the CPB machine to the patient, Medtronic ® or Terumo ® centrifugal pumps were used. Throughout the period of CPB, the temperature was maintained above 31
• C. Parametric data were described as mean, median, standard deviation, and minimum and maximum values. The groups were compared using non-parametric Mann---Whitney test. p-Values lower than 0.05 were considered as statistically significant.
Results
The study included 27 patients: 15 in the control and 12 in the clonidine group. The mean ages of the control group and of the clonidine group were 52.53 ± 13.10 and 51.75 ± 14.75 years (p = 0.885), respectively. The general characteristics of the groups are shown in Table 1 . The groups were homogenous in terms of ejection fraction, fractional shortening percentage, plasma creatinine and duration of CPB (Table 2) .
Plasma cortisol values in control and clonidine groups are shown in Table 3 .
Blood glucose values are shown in Table 4 . Table 5 displays serum lactate values in both groups. Troponin values for the two groups are shown in Table 6 . There was no statistical difference at the significance level of 5% for blood levels of troponin I, lactate, glucose and cortisol in all times analyzed in isolation. There was a statistically significant difference in blood glucose variation at times T3---T2 (p = 0.027) and T3---T1 (p = 0.047).
Discussion
The present study evaluated the effects of spinal clonidine on surgical stress response in patients undergoing cardiac surgery with CPB. The surgical trauma response is formed by complex hormonal and metabolic changes that profoundly alter homeostasis and participate in the morbidity and mortality observed in medium and major surgeries. The use of neuraxial clonidine in humans began in 1984. 16 Since then, numerous studies suggest that spinal clonidine potentiates the effects of opioids and local anesthetics. 7, 13 Therefore, when this association occurs, it may be difficult to separate the effects produced only by clonidine. Spinal clonidine not associated with other drugs or other forms of anesthesia was the object of analysis in a group of obstetric patients. The patients were randomly assigned to receive either 50, 100 or 200 g of subarachnoid clonidine in the first stage of labor. The results indicate that clonidine has an analgesic action in the spinal cord. The authors point out that the dose of 100 g offers the best dose-side effects relation. 17 It is known that the action of spinal clonidine is mediated by the activation of ␣-2 receptors in the substantia gelatinosa, with blockage of potassium conductance of fibers C and A. 18, 19 The drug also acts in the locus coeruleus by reducing the central release of norepinephrine, with attenuation of the central sympathetic action. 16, 20 Both actions could occur with intrathecal clonidine, which would act both in the dorsal horn of the spinal cord and in the locus coeruleus after migrating, through the liquor to the higher centers. There is, therefore, a theoretical basis to justify a protective action of clonidine on stress responses.
Troponin I, cortisol, glucose and lactic acid were the markers used in this study to identify stress responses and their modifications by the intervention of clonidine. These markers have already been extensively validated in previous studies. 21---26 In the present study only blood glucose exhibited more moderate elevation in the group receiving spinal clonidine. This suggests that somehow there was a lower activation of stress in this group. One cannot say that this glycaemic change has clinical significance, although with statistical significance. Thus, there is no sufficient evidence to contend that clonidine has a protective role in stress, when used by spinal route.
Conclusion
There were no statistically significant differences in troponin I, cortisol or lactic acid determinations between the groups. Blood glucose showed a more moderate increase in the group receiving spinal clonidine. We conclude that the use of clonidine at the spinal dose of 1 g kg −1 was not able to reduce the intensity of response to surgical trauma and showed only modest activity on glucose levels.
